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Abstract
Epigenetics describes modifications that affect gene expression that are not encoded 
within the DNA sequence. DNA methylation is the longest appreciated epigenetic modi-
fication and has been accepted to play a critical role in maintaining euchromatin and 
silencing genes. Recently, a separate and distinct covalent modification has been recog-
nized; hydroxymethylation, which has been associated with increased gene expression 
as opposed to gene silencing. However, traditional methods to study DNA methylation 
also recognized hydroxymethylation and did not distinguish between these two distinct 
DNA covalent modifications. Furthermore, TET enzymes have been identified to play 
a critical role in active hydroxymethylation of previously methylated cytosine residues 
and may further result in conversion to cytosine. TET1 plays a critical role in intesti-
nal epithelial differentiation and development, and this is also correlated with increased 
hydroxymethylation in terminally differentiated epithelial cells. Colon cancer, which 
arises from the colonic epithelium, exhibits decreased hydroxymethylation and altered 
gene expression.
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1. Introduction
Every cell in the human (and all mammalian) body contains the exact same genetic makeup 
with the exception of the gametes, which are haploid. However, despite containing the same 
DNA and genetic information there are a vast number of different cell types that perform 
functions essential to life. The difference in cell types is due to the genes that are selectively 
expressed, and those that are silenced combined with genes that are primed for activation 
in response to a stimulus. In this regard, the field of epigenetics is the study of mitotically 
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heritable changes/modifications to the genome that alters gene expression without changing 
the DNA sequence. There are three main types of epigenetic changes; specifically, noncod-
ing RNAs, covalent modifications or methylation to DNA, and histone modifications. In this 
chapter, we will focus primarily on covalent modifications to DNA: DNA methylation and 
hydroxymethylation and the role this process plays in colonic epithelial cells. The intesti-
nal epithelium has a rapid cellular turnover with the lifespan of a colonocyte being about 
4–5 days [1]. Within the colonic epithelium, there are several cell types, including colonocytes, 
goblet cells, and endocrine cells, all of which arise and differentiate from a common intesti-
nal stem cell located at the base of the crypts [1–3]. In this regard, the colonic epithelium is 
a unique system in which cellular differentiation and epigenetic alterations can be studied. 
Furthermore, two disease processes, colon cancer and ulcerative colitis integrally involve 
colonic epithelial cells. Alterations in DNA methylation and hydroxymethylation profiles are 
likely to play an important role in these processes. At the end of the chapter, we will discuss 
altered DNA hydroxymethylation in these disease states.
2. DNA methylation
DNA methylation was first discovered in 1948 in the calf thymus [4]. In the mid-1970s, two 
papers hypothesized that cytosine methylation could be a de novo process, could be inherited 
through somatic mutation through an enzymatic process, and result in the silencing of genes 
[5–7]. Methylation occurs at the 5C position of cytosine in regions of DNA that are rich in 
cytosine-guanine (CpG) dinucleotide. About 98% of the genome is deficient in CpG, with 
enrichment of CpGs clustered into “CpG islands,” which are typically located near the cen-
tromere and within/near promoters. Furthermore, we are now recognizing that CpGs exist 
within introns and exons of genes and these residues may also be methylated [8, 9]. DNA 
methylation plays a critical role in imprinting, X-chromosome inactivation in females and 
silencing of transposons, and maintaining chromosomal stability [9–11]. Given the critical 
role that methylation plays in imprinting and X-chromosome inactivation and the pathology 
that results from alterations in these processes, DNA methylation was thought to be a static 
process and only reprogrammed during gametogenesis and embryogenesis.
DNA methylation has been thought to play an important role in gene silencing. When CpG 
islands within a gene promoter are methylated, the gene is silenced. This occurs through 
binding of methyl binding proteins to methylated cytosine which results in histone recruit-
ment and heterochromatin, which is tightly condensed, thereby making the promoter inac-
cessible to transcription factors. However, recently, with improved technology and genetic 
sequencing, we have recognized that 5-mc may occur within a gene in introns and/or exons. 
Furthermore, 5-mc in intragenic regions may result in alternate splicing or transcripts [9, 12].
Importantly, cytosine methylation (5-mc) is preserved during mitosis through DNA meth-
yltransferase 1 (DNMT), which recognizes hemi-methylated DNA during the S-phase of 
mitosis and copies this pattern to the daughter strand [13–15]. This mechanism is essential to 
maintain tissue homogeneity and cell lineage in terminally differentiated cells, and there are 
many publications that have established DNA methylation profiles specific to certain  tissues 
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and additionally tissues or cells with similar functions have similar methylation profiles 
[16, 17]. Maintenance of DNA methylation is an essential function and a recent study on 
human embryonic stem cells demonstrated lethality when DNMT1 was deleted. Specifically, 
when DNMT1 was conditionally deleted after initial development, the cells rapidly lost meth-
ylation and underwent cell death [18]. In addition to DNTM1, which copies DNA methylation 
marks during cell division, DNMT 3a and 3b are able to methylate DNA de novo (Figure 1). 
In mouse models, deletion of DNMT1 or DNMT3b is embryonically lethal and deletion of 
DNMT3a results in postnatal lethality [19, 20].
3. Hydroxymethylation
Hydroxymethylation of cytosine was described shortly after DNA methylation in 1950. At 
that time hydroxymethylated cytosine was described in a bacteriophage and was suggested 
to be a mechanism by which the virus evaded DNA degradation by the host [21, 22]. Several 
studies in the 1970s described hydroxymethylated cytosine in mammals but it was not until 
2009 when high levels of hydroxymethylation were found in Purkinje cells [23]. Further stud-
ies revealed that there were detectable levels of 5-hmc across all tissue types with cells of 
the central nervous system containing the highest percent of hydroxymethylated cytosine 
residues [23].
Importantly, bisulfite sequencing that has traditionally been used to identify methylated 
cytosine bases only distinguishes covalently modified cytosine from unmodified cytosine, 
therefore methylated and hydroxymethylated cytosine were recognized as the same. With 
advances in technology and new interest in hydroxymethylation as having a potentially sepa-
rate function from methylated cytosine, we are now able to distinguish one from the other at 
the single nucleotide level [7, 24]. Importantly, while 5-mc rich regions are associated with 
heterochromatin and gene silencing, 5-hmc is associated with euchromatin and genes with 
rich in 5-hmc are accessible to transcription factors. Methylated cytosines may undergo oxi-
dation by the ten eleven ten (TET) enzymes resulting in 5-hydroxymethylcytosine (Figure 1). 
Further oxidation of 5-hmc by TET enzymes leads to 5-formylcytosine and 5-carboxylcytosine 
which are then excised and replaced by a new cytosine residue. In this regard, TET enzymes 
Figure 1. Cytosine may be methylated by DNA methyltransferases (DNMT) resulting in 5-methylcytosine (5-mc) which 
is associated with gene silencing when located in the promoter. 5-mc may be reduced by ten eleven ten (TET) enzymes 
resulting in 5-hydroxymethylcytosine (5-hmc) which is associated with euchromatin and gene transcription/activation.
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also function in active demethylation [25, 26]. Additionally as indicated previously in this 
chapter, 5-methylcytosine associates with methyl binding proteins which promote hetero-
chromatin formation, these methyl binding proteins are not able to recognize hydroxymeth-
ylated cytosine and this is another mechanism by which hydroxymethylation may serve to 
make genes more accessible. Finally, hydroxymethylation may facilitate passive demethyl-
ation as DNTM1 has low affinity for 5-hmc and during DNA replication lack of recognition of 
a previously methylated cytosine, now 5-hydroxymethylcytosine would not have the methyl 
mark copied to the daughter strand. Hydroxymethylation not only serves as an intermediate 
step in active demethylation, but is also fairly stable and present in relative abundance com-
pared to 5-flucytosine and 5-carboxylcytosine; therefore, hydroxymethylation may serve an 
additional and unique function [21, 26–29].
Studies that evaluate global DNA methylation or hydroxymethylation and gene expression 
have inconsistent results. As our sequencing technology and ability to distinguish 5-hmc from 
5-mc has improved, we are coming to understand that regions that are rich in 5-hmc may 
not be “activated” but rather be “poised for activation” through a delicate balance between 
5-mc, 5-hmc and activating (H3K4me3) and repressive (H3K27me3) histone marks [21, 30]. 
Furthermore, studies in the central nervous system have indicated that changes in specific 
5-hmc residues without change in overall methylation can have profound effects on gene 
expression [31]. Importantly the dynamics and abundance of 5-hmc is cell type specific and 
changes during development. In this regard, here we will examine the role of 5-hmc in intes-
tinal epithelial cell development and differentiation.
4. Intestinal epithelial cells
The colonic epithelium is one of the largest cellular compartments with a very rapid turnover. 
The intestinal epithelium is a single cell thick barrier that serves not only as a barrier to pro-
tect the underlying lamina propria immune cells from the luminal antigens and bacteria, but 
these cells also play a role in metabolism, water and nutrient absorption, sensing the luminal 
environment for potential pathogens, and maintaining a mucus barrier. The colonic epithe-
lium forms crypts and villi which increases the surface area and absorptive surface area. The 
intestinal epithelium is composed of four major cell types that arise from a common precursor 
cell. Enterocytes/colonocytes arise from intestinal stem cells which divide to become rapidly 
dividing transition zone cells, these cells divide up to six more times and migrate up to the 
tips of the villi during their differentiation. The enterocytes/colonocytes at the tips of the villi 
play a role in maintaining tight junctions as well as metabolic and absorptive functions, and 
have a short lifespan of 4–5 days after which they are sloughed off of the surface and mew 
cells must replace them. The intestinal epithelium also consists of mucin-producing goblet 
cells, endocrine cells and Paneth cells, which migrate down to the base of the crypts and play 
a role in bacterial sensing and are relatively long-lived. Over the past decade, we have come to 
understand that all of these cell types in the intestinal epithelium arise for a common progeni-
tor cell that resides in the transitional zone between the crypts and villi at the +5 position and 
are referred to as LGR5+ cells (intestinal stem cells) [1, 2].
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Culture of LGR+5 cells in a 3D matrigel (substituting for the extracellular membrane) supple-
mented with growth factors: WNT and Noggin to allow for stem cell expansion, R-spondin 
which maintains stem cell populations, and EGF to promote cell proliferation results in the 
development of a 3D structure with distinct crypt-like and villus-like structure with a central 
lumen referred to as organoids. Organoids have successfully been generated from both human 
and mouse LGR5 cells. These organoids contain all of the cell types present in the intestinal 
epithelium with crypt-like domains containing Paneth cells and LGR5+ stem cells, villi with 
villin-positive cells and also enteroendocrine and goblet cells scattered throughout the organ-
oid [3]. Organoids have successfully been generated from isolated LGR5+ cells supporting this 
notion of LGR5 cells as a pluripotent progenitor for the intestinal/colonic epithelium [3, 32].
Recently, studies have evaluated global methylation and hydroxymethylation in the colonic 
epithelium. These studies showed relatively similar levels of methylation in the crypts and 
in association with rapidly dividing (Ki67+) cells in the transition zone; whereas, there was 
an enrichment of hydroxymethylation at the tips of the villi and a decreased prevalence of 
hydroxymethylation in the crypts in Ki67-positive cells. These data suggest that hydroxy-
methylation is gained during differentiation and preferentially expressed in non-dividing, 
terminally differentiated cells [33].
Alterations in hydroxymethylation profiles in colonic epithelial cells can also be recapitulated 
in vitro. When T84 colonic epithelial cell line is cultured at low density in vitro, the cells lack polar-
ity, rapidly divide, and express low levels of global hydroxymethylation. However, as these cells 
divide and come into contact with other cells they differentiate and polarize to form a monolayer. 
This process is associated with an increase in hydroxymethylation specifically in promoters of 
genes involved in maintaining tight junctions, regulation of actin and endocytosis. Furthermore, 
enrichment in hydroxymethylation co-localizes with binding sites for colonic epithelial-specific 
transcription factors including HNF4A, RXRA and CDX2 with relatively little change in the 
hydroxymethylation status of GATA6 (Figure 2A). Importantly, this increase in hydroxymethyl-
ation also positively correlated with gene expression in a dose-dependent manner with the genes 
with the highest concentration of hydroxymethylation being the most highly expressed [34].
In mouse models, it is possible to separate the colonocytes at the villous from LGR5+ cells 
using a combination of cell scraping and LGR5 isolation by FACS when LGR5 expression is 
linked to a fluorescent indicator. This study also confirms that not only is there a difference 
in the abundance of hydroxymethylation in the LGR5+ cells compared to the terminally dif-
ferentiated enterocytes, but also that hydroxymethylation correlates with highly expressed or 
inducible cells and changes during differentiation. This study demonstrated that there were 
over 10,000 differentially hydroxymethylated regions between LGR5+ cells and colonocytes. 
Hydroxymethylation in LGR5+ cells localized to promoters of intestinal stem cell markers, 
such as LGR5, and gene ontology analysis revealed that the functions of the preferentially 
hydroxymethylated genes were involved in developmental processes, cell differentiation and 
other stem cell functions. In contrast, in the LGR5− colonocytes that were terminally differenti-
ated, hydroxymethylation was enhanced in the promoters and within genes that control met-
abolic processes, nutrient transport and other enterocyte functions, and genes with enriched 
hydroxymethylation also exhibited higher expression at the RNA level [33].
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TET1, which actively can convert methylated cytosine to hydroxymethylated cytosine in 
epithelial cells, is critical for intestinal epithelial cell maintenance and differentiation. In this 
regard, TET1-deficient mice exhibit colonic shortening, with shorter villi, with fewer LGR5+ 
cells. These mice are smaller than their littermate controls and ultimately deletion of Tet1 is 
lethal. Furthermore, LGR5+ cells derived from these TET1-deficient mice are also unable to 
form organoids, which confirms the role of TET1 and hydroxymethylation as a critical step in 
epithelial cell differentiation and maintenance [33, 35].
5. Hydroxymethylation in colon cancer
As we have discussed above, hydroxymethylation is critical in the differentiation of colonic 
epithelial cells, and there is a change specifically in the distribution of hydroxymethylation 
as cells divide and differentiate from the LGR5 cells in the crypts (hydroxymethylation in 
genes involved in proliferation and stem cell functions) and differentiated colonocytes at the 
tips of the villi (metabolic functions and tight junction). Colonic adenocarcinoma arises from 
the colonic epithelial cells and is the number two cause of cancer-related deaths in the United 
States. Traditionally, cancer progresses through four stages from adenomatous-type polyps 
to adenomas, to invasive disease and then metastasis. It has long been recognized that there 
Figure 2. Overview of the role of hydroxymethylation in (A) normal intestinal epithelium, (B) colon cancer and 
(C) proposed role in inflammatory bowel disease. (A) TET1 activity results in hydroxymethylation of specific cytosine 
residues as cells rapidly divide and migrate. This results in downregulation of the WNT signaling pathway (reduced 
proliferation) and upregulation of genes associated with the function of these terminally differentiated cells. (B) In 
colon cancer, there is decreased TET1 activity and therefore decreased overall hydroxymethylation which leads to 
a loss of organization, and increased cellular proliferation and inappropriate growth. (C) In IBD, we propose that 
aberrant hydroxymethylation may result in a decrease in hydroxymethylation of genes associated with barrier function, 
and downregulatory cytokines and/or increased hydroxymethylation (and therefore increased expression) of pro-
inflammatory cytokines.
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are aberrant methylation profiles in cancers including colon cancer, and the thought was that 
increased methylation of tumor suppressor genes would result in silencing of these genes and 
lead to malignant transformation and growth. However, until recently, bisulfite sequencing 
could not differentiate between methylation (associated with gene silencing when in the pro-
moter) and hydroxymethylation (associated with gene activation).
Since hydroxymethylation has now been appreciated in mammalian cells and it is now recog-
nized that hydroxymethylation has a distinct role in gene regulation and expression, recent 
attention has been turned to the role of hydroxymethylation in cancer. A recent study evalu-
ated global hydroxymethylation in colon cancer tissue compared to matched, adjacent nor-
mal tissue and demonstrated that hydroxymethylation was profoundly less in colon cancer 
tissue compared to normal [36]. Furthermore, Tet1, which as discussed is essential for active 
hydroxymethylation in intestinal epithelium cells, is decreased in colon cancer and occurs 
as an early event [37, 38]. Additionally, in other cancers such as breast cancer, decreased 
Tet1 expression is associated with more aggressive malignancy and metastatic disease [11]. 
Taken together, we may hypothesize that decreased Tet1 expression may result in altered/
decreased hydroxymethylation. In support of this hypothesis, the role of Tet1 in colon cancer 
was evaluated in the colonic epithelial cell line derived from colon adenocarcinoma CaCo2. CaCo2 cells were transfected with inducible Tet1 under control of doxycycline. When these cells were treated with doxycycline for 96 hours, these cells had slower growth and there 
were 300 genes with altered expression, and 60% of the genes with increased expression in 
the Tet1-induced state had enriched hydroxymethylation and correlated with genes that had 
high levels of methylation in the wild type (TET1low) cells. Gene ontology analysis showed sig-
nificant enrichment in the WNT/β-catenin signaling pathway of the TET1-deregulated genes. 
To support this notion, the nuclear level of b-catenin was decreased when TET1 expression 
was induced, supporting the notion that TET1 expression leads to decreased WNT/β-catenin 
signaling. Further studies showed that DDK3 and DDK4 which are upstream regulator of 
the WNT pathway were upregulated in the TET1-induced cells and these genes expressed a 
higher level of hydroxymethylation when compared to the wild type (Tet1low) cells (Figure 2B), 
this in turn provides a mechanistic explanation as to Tet1-induced downregulation of WNT 
through increased expression of WNT pathway inhibitors. Further studies were done using a 
xenograft system and TET1-induced CaCo2 cells implanted into a mouse resulted in smaller 
tumors than the wild-type CaCo2 xenografts [39].
Our group also evaluated hydroxymethylation in colon cancer compared to adjacent nor-
mal tissue in patients with colon cancer. While we did not find any specific pathways that 
exhibited decreased hydroxymethylation in colon cancer, we did identify numerous genes 
that lost hydroxymethylation and expression. Specifically, two of these genes include: FMN2 
(formin 2) and PCDC4 (programmed cell death 4). FMN2 is involved in the organization of 
actin cytoskeleton and cell polarity; therefore, decreased expression of this gene may result 
in decreased contact inhibition and the disorganization, which is seen in colonic adenocarci-
noma. Furthermore, PDCD4 is also downregulated and exhibits loss of hydroxymethylation 
in colon cancer. Loss of PDCD4 has been associated with colon adenocarcinoma and these 
tumors tend to be more aggressive [34, 40]. Additionally, there were also genes that gained 
hydroxymethylation and exhibited increased expression including BMP7 and TGFB1. Bone 
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morphogenetic protein 7 (BMP7) is a secreted protein of the TGF-β superfamily, and TGFB1 
(transforming growth factor beta 1) is known to be increased in tumor cells and may induce 
the canonical WNT signaling (Figure 2B) [34]. Taken together there is strong evidence that 
alterations to gene-specific hydroxymethylation profiles may be an early step that occurs in 
colon cancer leading to progression of disease. Altered hydroxymethylation may serve as a 
biomarker or predictor of disease severity and/or targets for future therapy.
6. Hydroxymethylation in IBD
Inflammatory bowel disease (IBD) affects more than 3 million adults (estimated 1.3% of 
adults) in the United States [41]. Importantly, the incidence of IBD has been increasing over 
the past 10 years especially in developed and developing countries. Furthermore, envi-
ronmental influences appear to influence IBD with the two major phenotypes, ulcerative 
colitis and Crohn’s disease, demonstrating opposite correlation with smoking. Specifically, 
smoking is protective in ulcerative colitis and patients may experience flares with cessation 
of smoking; whereas in Crohn’s disease, smoking worsens disease [42–44]. Recent studies 
including the GWAS have identified an important role for genetics as well as gene regulation 
and epigenetics in IBD [45, 46]. To date the GWAS have identified 163 loci that are associated 
with IBD; however, only approximately 10% of these loci are located in DNA coding regions 
suggesting an important role for gene regulation [47, 48]. Given that genetics account for 
only 10% of cases of IBD, the increased incidence in developing countries and the identified 
environmental influences, IBD is likely due to a gene by environment interaction, which 
also implicates epigenetics as a key driver in disease pathogenesis. Previous studies have 
implicated a role for alterations in DNA methylation in IBD; however, these studies showed 
discordant results in genes with “methylated” promoters and RNA expression. This may be 
due to the fact that these studies were performed prior to the development of the technol-
ogy to distinguish methylated cytosine (silenced genes) from hydroxymethylated cytosine 
(activated or primed for activation). Furthermore, these studies were performed in intact 
tissues or mixed cell populations [49]. Since methylation plays a critical role in maintain-
ing tissue homogeneity, and as described previously, hydroxymethylation is increased in 
terminally differentiated cells, methylation and hydroxymethylation are best evaluated in 
a single cell population. Since colonic epithelial cells are the most widely affected cell type 
in IBD, hydroxymethylation plays a critical role in colonic epithelial cell differentiation and 
function, and prior studies have suggested altered methylation profiles in IBD tissues, we 
may infer that there is a role for aberrant hydroxymethylation of genes, potentially involved 
in barrier function or cytokine production, that contributes to the pathogenesis of IBD 
(Figure 2C). Future studies to evaluate differential hydroxymethylation in epithelial cells 
from affected/unaffected mucosa from IBD patients may provide further insights into novel 
pathways or genes implicated in IBD pathophysiology. Additionally further understand-
ing into the mechanisms by which hydroxymethylation profiles are altered either through 
changes in TET expression or environmental exposures that promote or inhibit hydroxy-
methylation we may identify novel targets for therapy.
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7. Conclusion
Epigenetics, mitotically heritable changes/modifications to the genome that alter gene expres-
sion without changing the DNA sequence, plays a critical role in embryogenesis, normal 
development and disease. Specifically, DNA methylation has long been recognized as a 
critical epigenetic modification that is critical to normal function and tissue homogeneity. 
Alterations in methylation profiles have also been identified in and are thought to play a 
role in autoimmune diseases as well as malignancy. However, until recently technology did 
not allow for the differentiation between methylated cytosine (5-mc) and hydroxymethylated 
cytosine (5-hmc). Given that recent studies have indicated that hydroxymethylated promoters 
is associated with gene activation, it is important to further evaluate the role of hydroxymeth-
ylation in development and disease.
In this chapter, we have discussed the critical role of DNA hydroxymethylation in the differen-
tiation of intestinal epithelial cells. Differential hydroxymethylation of specific gene promoters 
results in appropriate function of the LGR5 stem cells and the differentiated enterocytes. We 
have also discussed that higher levels of hydroxymethylation are associated with terminally 
differentiated, non-dividing cells in the normal tissue. Furthermore, we implicated a role for 
hydroxymethylation in the pathogenesis of colonic adenocarcinoma through increased WNT 
signaling, and also differential hydroxymethylation in specific genes that may act as tumor 
suppressors or growth factors in paired tissue samples. Finally, we have presented evidence 
that supports a potential role for altered hydroxymethylation in IBD.
Future studies evaluating hydroxymethylation at the single nucleotide level in a single cell 
population may be extremely valuable in identifying potential novel pathways or drug targets 
in disease. Importantly, as discussed, hydroxymethylation is a stable epigenetic modification, 
but is also dynamic in that hydroxymethylation may be gained or lost at a specific location. 
This is important because altered hydroxymethylation in a cell population may result from 
a gene x environment interaction and then be propagated as cells divide, thereby leading to 
disease pathogenesis. In regards to the intestinal epithelium, use of organoids may allow 
researchers to identify environmental exposures to the epithelium that may result in altered 
hydroxymethylation. Furthermore, since the intestinal epithelium can easily be isolated from 
tissue specimens, further studies may be performed on paired specimens to delineate normal 
and diseased tissue in patients with IBD and colonic adenocarcinoma.
Abbreviations
5-hmC  5-hydroxymethylcytosine
5-mC  5-methylcytosine
CDX2  Caudal type homeobox 2
CpG  Cytosine-guanine dinucleotides
Hydroxymethylation Influences on Intestinal Epithelial Cells in Health and Disease
http://dx.doi.org/10.5772/intechopen.72989
135
ddk  Dickkopf WNT signaling pathway inhibitor
DNMT  DNA methyltransferase
FMN2  Formin-2
GATA6  GATA-binding protein 6
HNF4A  Hepatocyte nuclear factor 4 alpha
iSC  Intestinal stem cell
LGR5  Leucine-rich repeat-containing G-protein-coupled receptor 5
PDCD4  Programmed cell death 4
RXRA  Retinoid X receptor alpha
TET  Ten eleven ten enzyme
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